Synopsys - SNPS Stock Forecast, Price & News

Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company offers Fusion Design Platform that provides digital design implementation solutions; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. It also provides intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, SATA, MIPI, HDMI, and Bluetooth low energy applications; analog IP, including data converters and audio codecs; and system-on-chip (SoC) infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating-point components, and Arm AMBA interconnect fabric and peripherals. In addition, the company offers logic libraries and embedded memories; configurable processor cores and application-specific instruction-set processor tools for embedded applications; IP subsystems for audio, sensor, and data fusion functionality; and security IP solutions. Further, it provides Platform Architect solutions for SoC architecture analysis and optimization; virtual prototyping solutions; and HAPS FPGA-based prototyping systems, as well as a series of tools used in the design of optical systems and photonic devices. Additionally, the company offers security testing, managed services, programs and professional services, and training that enable its customers to detect and remediate security vulnerabilities, and defects in the software development lifecycle, as well as manufacturing solutions. It serves electronics, financial services, automotive, medicine, energy, and industrial areas. The company was incorporated in 1986 and is headquartered in Mountain View, California.

Synopsys Stock Down 0.6 %

Shares of SNPS Stock traded down $2.42 during trading on Tuesday, hitting $388.03. The company had a trading volume of 544 shares, compared to its average volume of 920,395. The stock's 50-day moving average is $328.56 and its two-hundred day moving average is $312.69. The stock has a market capitalization of $59.36 billion, a price-to-earnings ratio of 60.72, a price-to-earnings-growth ratio of 3.13 and a beta of 1.22. Synopsys has a 52 week low of $255.02 and a 52 week high of $391.17.

Synopsys (NASDAQ:SNPS - Get Rating) last released its quarterly earnings data on Wednesday, May 18th. The semiconductor company reported $1.89 earnings per share for the quarter, beating analysts' consensus estimates of $1.80 by $0.09. Synopsys had a return on equity of 18.23% and a net margin of 21.19%. The firm had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.25 billion. During the same quarter in the prior year, the firm posted $1.24 earnings per share. On average, research analysts predict that Synopsys will post 6.29 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Rosenblatt Securities upped their target price on shares of Synopsys from $360.00 to $390.00 and gave the company a "buy" rating in a research note on Friday. Needham & Company LLC increased their price target on shares of Synopsys from $370.00 to $380.00 and gave the company a "buy" rating in a research note on Thursday, May 19th. UBS Group cut their price target on shares of Synopsys to $360.00 and set a "hold" rating for the company in a research note on Thursday, May 19th. Bank of America raised shares of Synopsys from an "underperform" rating to a "neutral" rating and increased their price objective for the company from $325.00 to $360.00 in a research report on Wednesday, June 29th. Finally, Atlantic Securities lowered their price target on shares of Synopsys to $350.00 and set a "na" rating on the stock in a research report on Thursday, May 19th. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Synopsys presently has a consensus rating of "Moderate Buy" and an average target price of $387.20.

Insider Activity

In related news, CRO Joseph W. Logan sold 53,706 shares of the stock in a transaction on Friday, May 20th. The stock was sold at an average price of $299.12, for a total transaction of $16,064,538.72. Following the sale, the executive now directly owns 99,907 shares of the company's stock, valued at $29,884,181.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Synopsys news, insider John F. Runkel, Jr. sold 3,463 shares of Synopsys stock in a transaction that occurred on Tuesday, June 7th. The stock was sold at an average price of $330.00, for a total value of $1,142,790.00. Following the sale, the insider now owns 22,623 shares of the company's stock, valued at approximately $7,465,590. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CRO Joseph W. Logan sold 53,706 shares of the business's stock in a transaction that occurred on Friday, May 20th. The shares were sold at an average price of $299.12, for a total value of $16,064,538.72. Following the transaction, the executive now directly owns 99,907 shares in the company, valued at approximately $29,884,181.84. The disclosure for this sale can be found here. Insiders sold 129,285 shares of company stock worth $39,219,908 over the last three months. 1.20% of the stock is currently owned by corporate insiders.